Routine use of mupirocin to prevent staphylococcal infections is controvers
ial. We assessed attitudes and practices of healthcare professionals attend
ing the Fourth Decennial International Conference on Nosocomial and Healthc
are-Associated Infections regarding mupirocin prophylaxis. Eighty percent o
f participants did not use mupirocin routinely. At the end of the session,
58% indicated they would consider increased use of mupirocin.